{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T12:48:30Z","timestamp":1780058910988,"version":"3.54.0"},"reference-count":15,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,8,13]]},"DOI":"10.7759\/cureus.90013","type":"journal-article","created":{"date-parts":[[2025,8,13]],"date-time":"2025-08-13T19:58:52Z","timestamp":1755115132000},"source":"Crossref","is-referenced-by-count":1,"title":["Silent but Severe: A Case Report of a Large Retroperitoneal Hematoma Following Routine Intradetrusor Botulinum Toxin A Injections"],"prefix":"10.7759","author":[{"given":"Juho T","family":"Eineluoto","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jutta","family":"Jokinen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1016\/s0022-5347(17)60554-8","article-title":"A new flexible fibercystoscope for visualization of the bladder neck","volume":"109","author":"Tsuchida S","year":"1973","unstructured":"Tsuchida S, Sugawara H. A new flexible fibercystoscope for visualization of the bladder neck. J Urol. 1973, 109:830-1. 10.1016\/s0022-5347(17)60554-8","journal-title":"J Urol"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.4103\/0970-1591.109975","article-title":"The use of botulinum toxin for the treatment of overactive bladder syndrome","volume":"29","author":"Orasanu B","year":"2013","unstructured":"Orasanu B, Mahajan ST. The use of botulinum toxin for the treatment of overactive bladder syndrome. Indian J Urol. 2013, 29:2-11. 10.4103\/0970-1591.109975","journal-title":"Indian J Urol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/j.eururo.2013.10.033","article-title":"An updated systematic review and statistical comparison of standardised mean outcomes for the use of botulinum toxin in the management of lower urinary tract disorders","volume":"65","author":"Mangera A","year":"2014","unstructured":"Mangera A, Apostolidis A, Andersson KE, et al.. An updated systematic review and statistical comparison of standardised mean outcomes for the use of botulinum toxin in the management of lower urinary tract disorders. Eur Urol. 2014, 65:981-90. 10.1016\/j.eururo.2013.10.033","journal-title":"Eur Urol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1097\/00005392-200009010-00018","article-title":"Botulinum-A toxin for treating detrusor hyperreflexia in spinal cord injured patients: a new alternative to anticholinergic drugs? Preliminary results","volume":"164","author":"Schurch B","year":"2000","unstructured":"Schurch B, St\u00f6hrer M, Kramer G, Schmid DM, Gaul G, Hauri D. Botulinum-A toxin for treating detrusor hyperreflexia in spinal cord injured patients: a new alternative to anticholinergic drugs? Preliminary results. J Urol. 2000, 164:692-7. 10.1097\/00005392-200009010-00018","journal-title":"J Urol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1097\/MJT.0000000000001637","article-title":"Update on overactive bladder therapeutic options","volume":"31","author":"Babin CP","year":"2024","unstructured":"Babin CP, Catalano NT, Yancey DM, et al.. Update on overactive bladder therapeutic options. Am J Ther. 2024, 31:e410-9. 10.1097\/MJT.0000000000001637","journal-title":"Am J Ther"},{"key":"ref6","unstructured":"Medication guide. Botox\u00ae cosmetic (Boe-tox) (onabotulinumtoxinA) for injection. (2016). Accessed. May 31, 2025: https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2012\/103000Orig1s5253mg.pdf."},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1089\/end.2005.19.880","article-title":"Simplified bladder botulinum-toxin delivery technique using flexible cystoscope and 10 sites of injection","volume":"19","author":"Smith CP","year":"2005","unstructured":"Smith CP, Chancellor MB. Simplified bladder botulinum-toxin delivery technique using flexible cystoscope and 10 sites of injection. J Endourol. 2005, 19:880-2. 10.1089\/end.2005.19.880","journal-title":"J Endourol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1007\/s00345-025-05617-1","article-title":"Ensuring patient safety during cystocopy: risk assessment of device reprocessing through healthcare failure mode and effects analysis","volume":"43","author":"Redin MR","year":"2025","unstructured":"Redin MR, Perez CD, Valdes CB, Jose-Saras DS, Moreno-Nunez P, Vicente-Guijarro J, Aranaz-Andres JM. Ensuring patient safety during cystocopy: risk assessment of device reprocessing through healthcare failure mode and effects analysis. World J Urol. 2025, 43:258. 10.1007\/s00345-025-05617-1","journal-title":"World J Urol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1046\/j.1464-4096.2001.01899.x","article-title":"The community-based morbidity of flexible cystoscopy","volume":"89","author":"Burke DM","year":"2002","unstructured":"Burke DM, Shackley DC, O'Reilly PH. The community-based morbidity of flexible cystoscopy. BJU Int. 2002, 89:347-9. 10.1046\/j.1464-4096.2001.01899.x","journal-title":"BJU Int"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1016\/j.eururo.2010.09.007","article-title":"Adverse events of intravesical botulinum toxin A injections for idiopathic detrusor overactivity: risk factors and influence on treatment outcome","volume":"58","author":"Kuo HC","year":"2010","unstructured":"Kuo HC, Liao CH, Chung SD. Adverse events of intravesical botulinum toxin A injections for idiopathic detrusor overactivity: risk factors and influence on treatment outcome. Eur Urol. 2010, 58:919-26. 10.1016\/j.eururo.2010.09.007","journal-title":"Eur Urol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1038\/sj.sc.3101318","article-title":"Muscular weakness as side effect of botulinum toxin injection for neurogenic detrusor overactivity","volume":"40","author":"Wyndaele JJ","year":"2002","unstructured":"Wyndaele JJ, Van Dromme SA. Muscular weakness as side effect of botulinum toxin injection for neurogenic detrusor overactivity. Spinal Cord. 2002, 40:599-600. 10.1038\/sj.sc.3101318","journal-title":"Spinal Cord"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.74754","article-title":"A large pelvic haematoma caused by a local anaesthetic flexible cystoscopy injection of intradetrusor botulinum toxin A: a case report","volume":"16","author":"Atayi A","year":"2024","unstructured":"Atayi A, Al-Gburi S, Hamdoon M, Patrick N. A large pelvic haematoma caused by a local anaesthetic flexible cystoscopy injection of intradetrusor botulinum toxin A: a case report. Cureus. 2024, 16:e74754. 10.7759\/cureus.74754","journal-title":"Cureus"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1016\/j.juro.2008.01.118","article-title":"Ultrasound measurement of bladder wall thickness in the assessment of voiding dysfunction","volume":"179","author":"Blatt AH","year":"2008","unstructured":"Blatt AH, Titus J, Chan L. Ultrasound measurement of bladder wall thickness in the assessment of voiding dysfunction. J Urol. 2008, 179:2275-8. 10.1016\/j.juro.2008.01.118","journal-title":"J Urol"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1016\/j.urology.2021.05.008","article-title":"The economics of cystoscopy: a microcost analysis","volume":"157","author":"Kenigsberg AP","year":"2021","unstructured":"Kenigsberg AP, Gold S, Grant L, Lotan Y. The economics of cystoscopy: a microcost analysis. Urology. 2021, 157:29-34. 10.1016\/j.urology.2021.05.008","journal-title":"Urology"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1007\/s00192-023-05685-0","article-title":"Injection site number and outcomes of intradetrusor onabotulinumtoxinA for refractory overactive bladder syndrome: a randomized clinical trial","volume":"35","author":"Zdroik A","year":"2024","unstructured":"Zdroik A, El Haraki A, Smith W, Badlani G, Parker-Autry C, Matthews C. Injection site number and outcomes of intradetrusor onabotulinumtoxinA for refractory overactive bladder syndrome: a randomized clinical trial. Int Urogynecol J. 2024, 35:119-26. 10.1007\/s00192-023-05685-0","journal-title":"Int Urogynecol J"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/385590-silent-but-severe-a-case-report-of-a-large-retroperitoneal-hematoma-following-routine-intradetrusor-botulinum-toxin-a-injections","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,13]],"date-time":"2025-08-13T19:58:53Z","timestamp":1755115133000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/385590-silent-but-severe-a-case-report-of-a-large-retroperitoneal-hematoma-following-routine-intradetrusor-botulinum-toxin-a-injections"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,13]]},"references-count":15,"URL":"https:\/\/doi.org\/10.7759\/cureus.90013","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,8,13]]}}}